Genetic Technology--Patent Trends across Gene Editing

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This edition of the Genetic Technology Technology Opportunity Engine (TOE) depicts the current landscape and the new life sciences trends across Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) gene editing mechanisms and cell therapies. The study covers the institutions involved in the CRISPR patent battle and the licensing agreements evolved through CRISPR-Cas9 patent scenario, as well as, the first stem cell-based therapy approved in Europe and antigen-specific T cell platforms for development of cell therapies. The corresponding analyst insights on gene editing patents, the overall patent scenario, along with the industry interactions, are exhibited.

The Genetic Technology TOE presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), CRISPR-Cas9, CRISPR/Cas9, gene editing, cell therapy, CRISPR patent battle, CRISPR licensing agreements, stem cells, antigen-specific T cell platform

Table of Contents

Genetic Technology--Patent Trends across Gene EditingTrend-Based Technology ProfilesInstitutions Involved in the CRISPR Patent Battle License Agreements Evolved through CRISPR-Cas9 Patent ScenarioRepercussions of CRISPR Patent Battle across other Regions Innovations that Stemmed off CRISPR- Cas9Strategic PerspectivesStrategic PerspectivesAppendixPatent ScenarioPatent Scenario (continued)Industry Interactions




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.